Screening for PIK3CA, RAS, and RAF mutations in trials with PI3K/AKT/mTOR signaling pathway inhibitors

被引：0
|
作者：
Janku, F.
Tsimberidou, A. M.
Garrido-Laguna, I.
Hong, D. S.
Naing, A. M.
Falchook, G. S.
Fu, S.
Luthra, R. [1 ]
Wang, X. [2 ]
Kurzrock, R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Mol Diagnost Lab, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)71959-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Recent syntheses of PI3K/Akt/mTOR signaling pathway inhibitors
    Welker, Mark E.
    Kulik, George
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (14) : 4063 - 4091
  • [22] Targeting PI3K/AKT Pathway is an Effective Strategy for the Treatment of Neuroendocrine Tumors Harboring PIK3CA Mutations
    Song, Jun
    Li, Jing
    Kim, Ji Tae
    Weiss, Heidi
    Townsend, Courtney M.
    Evers, B. N.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S116 - S117
  • [23] PI3K signaling pathway is activated by PIK3CA mRNA overexpression and copy gain in prostate tumors, but PIK3CA, BRAF, KRAS and AKT1 mutations are infrequent events
    Agell, Laia
    Hernandez, Silvia
    Salido, Marta
    de Muga, Silvia
    Juanpere, Nuria
    Arumi-Uria, Montserrat
    Menendez, Silvia
    Lorenzo, Marta
    Lorente, Jose A.
    Serrano, Sergio
    Lloreta, Josep
    [J]. MODERN PATHOLOGY, 2011, 24 (03) : 443 - 452
  • [24] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Vasan, Neil
    Razavi, Pedram
    Johnson, Jared L.
    Shao, Hong
    Shah, Hardik
    Antoine, Alesia
    Ladewig, Erik
    Gorelick, Alexander
    Lin, Ting-Yu
    Toska, Eneda
    Xu, Guotai
    Kazmi, Abiha
    Chang, Matthew T.
    Taylor, Barry S.
    Dickler, Maura N.
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Rabadan, Raul
    Reznik, Ed
    Smith, Melissa L.
    Sebra, Robert
    Schimmoller, Frauke
    Wilson, Timothy R.
    Friedman, Lori S.
    Cantley, Lewis C.
    Scaltriti, Maurizio
    Baselga, Jose
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [25] PIK3CA status as a predictor of benefit from drugs targeting the PI3K/AKT/mTOR pathway: A meta-analysis of randomized trials
    Almugbel, Fahad A.
    Saleh, Ramy
    Ocana, Alberto
    Pandiella, Atanasio
    Amir, Eitan
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [26] Clonality of PIK3CA mutations (mut) and efficacy of PI3K/AKT/mTOR inhibitors (PAMi) in patients (pts) with metastatic breast cancer (MBC).
    Oliveira, Mafalda
    Dienstmann, Rodrigo
    Bellet, Meritxell
    Perez-Garcia, Jose Manuel
    Gomez-Pardo, Patricia
    Munoz-Couselo, Eva
    Vidal, Maria
    Ortega, Vanessa
    Soberino, Jesus
    Zamora, Esther
    Hierro, Cinta
    Ruiz, Fiorella
    Nuciforo, Paolo
    Vivancos, Ana
    Cortes, Javier
    Saura, Cristina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
    S N Payne
    M E Maher
    N H Tran
    D R Van De Hey
    T M Foley
    A E Yueh
    A A Leystra
    C A Pasch
    J J Jeffrey
    L Clipson
    K A Matkowskyj
    D A Deming
    [J]. Oncogenesis, 2015, 4 : e169 - e169
  • [28] PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
    Payne, S. N.
    Maher, M. E.
    Tran, N. H.
    Van De Hey, D. R.
    Foley, T. M.
    Yueh, A. E.
    Leystra, A. A.
    Pasch, C. A.
    Jeffrey, J. J.
    Clipson, L.
    Matkowskyj, K. A.
    Deming, D. A.
    [J]. ONCOGENESIS, 2015, 4 : e169 - e169
  • [29] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Vasan, Neil
    Razavi, Pedram
    Johnson, Jared L.
    Shao, Hong
    Shah, Hardik
    Antoine, Alesia
    Ladewig, Erik
    Gorelick, Alexander
    Lin, Ting-Yu
    Toska, Eneda
    Xu, Guotai
    Kazmi, Abiha
    Chang, Matthew T.
    Taylor, Barry S.
    Dickler, Maura N.
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Rabadan, Raul
    Reznik, Ed
    Smith, Melissa L.
    Sebra, Robert
    Schimmoller, Frauke
    Wilson, Timothy R.
    Friedman, Lori S.
    Cantley, Lewis C.
    Scaltriti, Maurizio
    Baselga, Jose
    [J]. SCIENCE, 2019, 366 (6466) : 714 - +
  • [30] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    [J]. JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
12345